Catalent (CTLT) Tops Q3 EPS by 2c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Catalent, Inc. Reports Third Quarter Fiscal 2020 Results
May 5, 2020 7:28 AM EDTQ3'20 revenue of $760.6 million increased 23% as-reported, or 25% in constant currency, from Q3'19. Solid organic revenue growth in all four segments. Reporting net debt leverage of 3.8x as of March 31 vs 4.2x at December 31, 2019; more than $600 million in cash and cash equivalents on-hand; growth capital projects continue on schedule. Completed the acquisition of MaSTherCell, a technology-focused cell and gene therapy development and manufacturing partner, on February 10, 2020. Revising FY'20 financial guidance range modestly to reflect fluid COVID-19 situation; long-term fundamentals remain... More
